Clinical Trial Update: Electrical Stimulation Therapy Using the MC5-A Scrambler in Reducing Peripheral Neuropathy Caused by Chemotherapy [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating MC5-A Scrambler electrical stimulation for chemotherapy-induced peripheral neuropathy completed, with results posted in 2013. The study…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer-related Pain
• Chemotherapy-induced Peripheral Neuropathy
• Neurotoxicity
• Peripheral Neuropathy

Snippet

Sponsor: Virginia Commonwealth University | Conditions: Chemotherapeutic Agent Toxicity, Neurotoxicity | Phase 2 | Status: COMPLETED | Results posted: 2013-03-22